Pharmacokinetic and Pharmacodynamic Characteristics of Canakinumab in Patients with Periodic Fever Syndromes: Results from a Phase III Pivotal Umbrella Trial

Yazar
Bujan-Rivas, Segundo
Frenkel, Joost
Anton, Jordi
Livneh, Avi
Ben-Chetrit, Eldad
Brogans, Paul
Xu, Lucy
Constantin, Minas
De Benedetti, Fabrizio
Gattorno, Marco
Gül, Ahmet
Hoffman, Hal M.
Kone-Paut, Isabelle
Lachmann, Helen
ÖZEN, SEZA
Simon, Anna
Van der Hilst, Jeroen
Zeft, Andrew
Speziale, Antonio
Junge, Guido
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/138011
Koleksiyonlar